文献速递糖尿病

比较胰岛素抵抗替代指标预测2型糖尿病的能力

Comparing surrogate indexes for insulin resistance as predictors of type 2 diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该队列研究纳入2260名美国西南部原住民,随访至14.5年(509例T2D),比较18种胰岛素抵抗替代指标预测T2D的能力。基于OGTT的指标预测最佳,Gutt和Cederholm的AUC最高(均为0.728);仅用空腹胰岛素的指标中QUICKI和HOMA-IR表现最好(r=0.644,AUC=0.701);不需胰岛素测量的指标中METS-IR的AUC最高(0.688)。

要点

  • 基于OGTT的替代指标预测T2D能力最佳。
  • 仅用空腹胰岛素的指标优于不需胰岛素测量的指标。
  • 不需胰岛素测量的指标中METS-IR表现最佳。

核心结论

  • 基于OGTT的替代指标预测T2D最佳,基于空腹胰岛素的指标优于不测量胰岛素的指标。

研究设计与样本

  • 美国西南部原住民队列研究,纳入2260人,随访至14.5年,发生509例T2D。
  • 在286人中用高胰岛素-正葡萄糖钳夹测定的胰岛素敏感性(M)评估各指标相关系数。

主要发现

  • OGTT计算的指标表现最佳,Matsuda与M的r最高(0.691)。
  • Gutt和Cederholm的AUC最高(均为0.728,P < .05,优于其他所有指标)。
  • 仅用空腹胰岛素的指标中,QUICKI和HOMA-IR的r均为0.644,AUC均为0.701。
  • 不需胰岛素测量的指标中,METS-IR和单点胰岛素敏感性指数的r分别为0.597和0.595,METS-IR的AUC最高(0.688)。

关键数值与推荐

  • 以高胰岛素-正葡萄糖钳夹测定的M为参照,Matsuda的r=0.691。
  • Gutt和Cederholm的AUC均为0.728,P < .05(与其他所有指标比较)。
  • QUICKI和HOMA-IR的r均为0.644,AUC均为0.701。
  • METS-IR的r=0.597,AUC=0.688;单点胰岛素敏感性指数的r=0.595。

临床怎么用

  • 在可进行OGTT时,优先选用基于OGTT的替代指标预测T2D风险。
  • 若仅能测空腹胰岛素,可选用QUICKI或HOMA-IR。
  • 若无法测胰岛素,可选用METS-IR。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Decreased insulin sensitivity (insulin resistance) is associated with increased type 2 diabetes (T2D) risk. Identifying reliable surrogate indexes that use standard clinical assays might improve the prevention of T2D. OBJECTIVE: The objective was to compare the ability of 18 surrogate indexes of insulin resistance to predict T2D. DESIGN: Cohort study of indigenous Americans from the southwest United States. SETTING: Community-based longitudinal study. PATIENTS AND OTHER PARTICIPANTS: We studied T2D risk in 2260 people followed for up to 14.5 years (509 cases of T2D). We estimated correlation coefficients (r) of all indexes with sensitivity (M) measured by hyperinsulinemic-euglycemic clamp in 286 persons. We calculated indexes obtained from oral glucose tolerance tests (OGTTs) using fasting and 2-hour glucose and insulin measures. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Predictive performance was assessed by the hazard ratio per SD and by the area under the receiver operating curve (AUC). RESULTS: Indexes calculated from OGTTs performed best; Matsuda had the highest r with M (0.691); Gutt and Cederholm had the highest AUCs (0.728 and 0.728, P < .05 compared with all other indexes). In indexes that only used fasting insulin levels, the quantitative insulin sensitivity check index and Homeostatic Model for Insulin Resistance had the best performance with equal r (0.644) and AUC (0.701). Among indexes that did not require insulin measurement, the metabolic score for insulin resistance (METS-IR) and single-point insulin sensitivity index had the highest r (0.597 and 0.595), while METS-IR had the highest AUC (0.688). CONCLUSION: Surrogate measures based on OGTTs are best for predicting T2D, while measures based on fasting insulin perform better than those that do not measure insulin.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Vazquez L, Vazquez Arreola E, Nagul M, et al. Comparing surrogate indexes for insulin resistance as predictors of type 2 diabetes. J Clin Endocrinol Metab. 2026. PMID: 41805838. doi:10.1210/clinem/dgag101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。